Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
opevesostat (MK-5684)
i
Other names:
MK-5684, ODM-208, ODM 208, ODM208, MK 5684, MK5684
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Merck (MSD), Orion Corp
Drug class:
CYP11A1 inhibitor
Related drugs:
‹
ODM-209 (0)
ODM-209 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
AR mutation
Prostate Cancer
AR mutation
Prostate Cancer
MK-5684
Sensitive: C3 – Early Trials
MK-5684
Sensitive
:
C3
MK-5684
Sensitive: C3 – Early Trials
MK-5684
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login